Treatment for MS may be divided into three different categories: symptomatic treatment, relapse management, and treatment aimed at the reduction of the risk of relapses as well as disability.
Symptomatic treatment does not alter the disease process but is aimed at relieving symptoms. Treatment of relapses will usually reduce symptoms and the resultant disability associated with the relapse more quickly than would occur naturally, but it does not alter the disease process either. A reduction of relapses will, of course, reduce temporary disability associated with attacks but is most meaningful if it reduces the risk of disability.
Narcotics derived from the Greek word for stupor, that originally referred to a variety of substances that dulled the senses and relieved pain. Epilepsy a brain disorder that occurs when the electrical signals in the brain are disrupted leading to a seizure. People with epilepsy have repeated seizures. Spasticity velocity-dependent increase in muscle tone.
Fatigue and urinary tract complaints are among the most common symptoms that MS patients may experience that are amenable to treatment. Many disturbances of sensation are highly subjective symptoms. Not uncommonly, a feeling of numbness is present only when attention is focused on the particular complaint, and it does not interfere with daily activity. Painful sensations may be favorably affected by treatment. Generally, the more severe the pain, the more likely it will be alleviated by medication.
Narcotics are not indicated. Drugs used in the management of epilepsy are the mainstay of pain management in MS, although other drugs may also be helpful. The manifestations of spasticity, such as stiffness and muscle spasms, can be greatly benefited by treatment.
Was this article helpful?